Dyne Therapeutics share price logo

Dyne Therapeutics

NASDAQ: DYN

Mid Cap

$16.94

+1.22

(+7.76%)

as on

Dyne Therapeutics Stock Performance

as on October 28, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $15.73
    $16.97
    downward going graph

    7.14%

    Downside

    0.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $14.00
    $27.31
    downward going graph

    17.36%

    Downside

    61.19%

    Upside

    downward going graph

Dyne Therapeutics share price movements today

Previous Close
$15.72
Open
$15.91
Volume
2.5M
Market Cap
$2.9B
Day's Low - High
$15.73 - $16.97
52 Week Low - High
$14.00 - $27.31

Dyne Therapeutics Historical Returns

1 Month Return
+ 3.67 %
3 Month Return
-34.59 %
1 Year Return
-30.26 %
3 Year Return
+ 155.89 %
5 Year Return
+ 16.67 %

Dyne Therapeutics Stock Fundamentals & Key Indicators

Check Dyne Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9B

EPS (TTM)

-3.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.72

Industry PE ratio

-9.06

PEG Ratio

-0.33

EBITDA

-495.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-64.30%

Dyne Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dyne Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.9B16.67%-4.720.00%0.00%
Neutral$79.4B-40.22%-24.92-12.57%0.00%
StrongBuy$131.2B186.28%29.8886.04%0.00%
Buy$83.2B30.54%19.2984.86%0.46%

Stock Returns calculator for Dyne Therapeutics Stock including INR - Dollar returns

The Dyne Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Dyne Therapeutics investment value today

Current value as on today

₹75,191

Returns

-₹24,809

(-24.81%)

Returns from Dyne Therapeutics Stock

-₹30,259 (-30.26%)

Dollar Impact

₹5,451 (+5.45%)

Analyst Recommendation on Dyne Therapeutics Stock

Based on 6 analysts

BUY

83.33%

Buy

0.00%

Hold

16.67%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Dyne Therapeutics. Average target price of $35.73

Dyne Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Dyne Therapeutics.

What analysts predicted

52.59%UPSIDE

Target Price

$35.73

Current Price

$16.94

Analyzed by

6 Analysts

High

$50

Target

$35.73

Low

$10

Dyne Therapeutics target price $35.73, a slight upside of 52.59% compared to current price of $16.94. According to 6 analysts rating.

Indian Investors' Interest in Dyne Therapeutics Stock

Search interest for Dyne Therapeutics Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-46% versus previous 30 day period

Dyne Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
0
-
Operating Income
-69
-71
-105
-97
-122
-115
-113
-116
-125
-181
EBITDA
-65
-64
-96
-89
-114
-110
-104
-101
-116
-173
Interest Expense
-
-
-
-
-
0
2
3
4
4
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-65
-65
-97
-89
-115
-110
-108
-111
-120
-178
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-65
-65
-97
-89
-115
-110
-108
-111
-120
-178
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dyne Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
506
-
-
-
-
-
-
-
-
Gross Profit
-2,426
0
0
0
-
-
-2
-2
-2
Operating Income
-412
-4
-13
-58
-150
-170
-242
-343
-468
EBITDA
949
-4
-14
-58
-148
-163
-234
-315
-437
Interest Expense
616
0
-
0
-
2
-
-
6
Depreciation
867
0
0
0
1
1
1
1
2
Income Before Tax
-538
-4
-14
-59
-149
-168
-235
-317
-446
Income Tax Expense
-610
0
-
0
-
-
-
-
-
Net Income
76
-4
-13
-58
-149
-168
-235
-317
-446
Net Profit Margin
-479.45%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dyne Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-65
-65
-97
-89
-115
-110
-108
-111
-120
-178
Operating Cash Flow
-78
-54
-74
-84
-105
-94
-90
-111
-144
-130
Investing Cash Flow
-179
11
-19
-16
1
6
-37
0
-2
-4
Financing Cash Flow
408
379
18
3
141
100
217
430
7
58
Change in Cash
150
336
-76
-96
36
12
88
320
-140
-76

Dyne Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
76
-4
-14
-59
-149
-168
-235
-317
-446
Operating Cash Flow
585
-4
-11
-46
-119
-153
-188
-292
-403
Investing Cash Flow
-2,759
0
-1
-45
-137
87
83
-204
-28
Financing Cash Flow
-1,299
12
19
380
157
37
54
809
890
Change in Cash
-3,473
12
6
288
-99
-29
-50
313
458

Global Institutional Holdings in Dyne Therapeutics

Check out the Institutions with significant holdings in Dyne Therapeutics.

Funds
Holdings
Vanguard
6.45%
VANGUARD INDEX FUNDS
4.84%
iShares
3.97%
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.
3.75%
SPDR
2.77%

Dyne Therapeutics News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 10:32 PM

    -

    Dyne Therapeutics shares fell nearly 18% after Novartis's trial failure raised concerns about similar therapies for myotonic dystrophy type 1.

    Wed, 02:05 AM

    -

    JPMorgan downgraded Dyne Therapeutics to Underweight, citing risks from Novartis's trial miss affecting Dyne's upcoming trial.

Insights on Dyne Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DYN stock has moved up by 5.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.4% return, outperforming this stock by 750.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 189.2% return, outperforming this stock by 33.3%

About Dyne Therapeutics

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
OrganisationDyne Therapeutics
Headquarters1560 Trapelo Road, Waltham, MA, 02451, US
IndustryBiotechnology
CEOJohn G. Cox

Key Management of Dyne Therapeutics

Name

Title

Dr. Axel Wiest

Senior VP and Head of Portfolio Strategy & Operations

Mr. James P. Bilotta M.B.A.

Chief Digital & Information Officer

Ms. Lucia Celona

Chief Human Resource Officer

Dr. Douglas Kerr M.B.A., M.D., Ph.D.

Chief Medical Officer

Dr. Rajesh Manchanda Ph.D.

Chief Technical Officer

Mr. Alessandro Martuscelli

Chief Legal Officer

Mr. John G. Cox M.B.A.

CEO, President & Director

Mr. Erick J. Lucera C.F.A., CPA

CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer

Dr. Oxana Beskrovnaya Ph.D.

Chief Innovation Officer

Ms. Johanna Friedl-Naderer

Chief Commercial Officer

FAQs

What is Dyne Therapeutics share price today?

Dyne Therapeutics share price today is $16.94 as on at the close of the market. Dyne Therapeutics share today touched a day high of $16.97 and a low of $15.73.

What is the 52 week high and 52 week low for Dyne Therapeutics share?

Dyne Therapeutics share touched a 52 week high of $27.31 on and a 52 week low of $14.00 on . Dyne Therapeutics stock price today i.e. is closed at $16.94,which is 37.96% down from its 52 week high and 21.00% up from its 52 week low.

What is Dyne Therapeutics's market capitalisation today?

Dyne Therapeutics market capitalisation is $0.00T as on .

How to invest in Dyne Therapeutics Stock (DYN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dyne Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Dyne Therapeutics Stock (DYN) from India?

Indian investors can start investing in Dyne Therapeutics (DYN) shares with as little as ₹95.12000274658203 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.20 in Dyne Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Dyne Therapeutics share’s latest price of $16.94 as on October 28, 2026 at 8:45 am IST, you will get 0.5903 shares of Dyne Therapeutics. Learn more about fractional shares .

What are the returns that Dyne Therapeutics has given to Indian investors in the last 5 years?

Dyne Therapeutics stock has given 16.67% share price returns and 26.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?